![]() Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | ![]() Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | ![]() Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. | |
Founding Date | Founding Date 1983 | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US | Locations Waltham, US HQ Lawrence, US | Locations Austin, US HQ Curitiba, BR Dubai, AE |
Employees | Employees 1608% increase | Employees 35037% increase | Employees 47 |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2025) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $200k (FY, 2025) | Cost of goods $3.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $1.3m (FY, 2025) | Gross profit $159.6m (FY, 2023) | Gross profit N/A |
Net income | Net income ($258.8m) (FY, 2025) | Net income ($194.9m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 2m | Total funding raised $ 714m | Total funding raised N/A |

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company
Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View company